Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China

被引:47
作者
Shi, Ming [1 ]
Chen, Ji-An [1 ]
Lin, Xiao-Jun [1 ]
Guo, Rong-Ping [1 ]
Yuan, Yun-Fei [1 ]
Chen, Min-Shan [1 ]
Zhang, Ya-Qi [1 ]
Li, Jin-Qing [1 ]
机构
[1] Sun Yat Sen Univ, Dept Hepatobiliary, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China
关键词
Hepatocellular carcinoma; Transarterial chemoembolization; Palliative treatment; Prognosis; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; RANDOMIZED CONTROLLED TRIAL; PROGNOSTIC-FACTORS; NATURAL-HISTORY; LIVER-CANCER; MANAGEMENT; SURVIVAL; COHORT; EMBOLIZATION; CIRRHOSIS;
D O I
10.3748/wjg.v16.i2.264
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To identify prognostic factors from pretreatment variables of the initial transarterial chemoembolization (TACE) procedure in unresectable hepatocellular carcinoma (HCC). METHODS: One thousand and five hundred and sixty-nine patients with unresectable HCC underwent TACE as initial treatment were retrospectively studied. Pretreatment variables of the initial TACE procedure with a P value less than 0.05 by univariate analysis were subjected to Cox proportional hazards model. RESULTS: The median overall survival time and 1-, 5-, 10-year survival rates were 10.37 mo, 47%, 10%, and 7%, respectively. A Cox proportional hazard model showed that 8 pretreatment factors of regional lymph nodes metastasis, Child-Pugh class, macrovascular invasion, greatest dimension, alpha-fetoprotein (AFP), Hepatitis virus B, tumor capsule, and nodules were independent prognostic factors. Patients with multimodality therapy have better survival than those with TACE treatment only. CONCLUSION: Tumor status, hepatic function reserve, AFP, and hepatitis virus B status were independent prognostic factors for unresectable HCC. Distant metastasis might not be a contraindication to TACE. Multimodality therapy might improve survival. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 30 条
[1]   Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma [J].
Ahmad, SA ;
Bilimoria, MM ;
Wang, XM ;
Izzo, F ;
Delrio, P ;
Marra, P ;
Baker, TP ;
Porter, GA ;
Ellis, LM ;
Vauthey, JN ;
Dhamotharan, S ;
Curley, SA .
JOURNAL OF GASTROINTESTINAL SURGERY, 2001, 5 (05) :468-476
[2]  
[Anonymous], 2002, AJCC CANC STAGING HD
[3]   Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma:: results from two French clinical trials [J].
Bonnetain, Franck ;
Paoletti, Xavier ;
Collette, Sandra ;
Doffoel, Michel ;
Bouche, Olivia ;
Raoul, Jean Luc ;
Rougier, Philippe ;
Masskouri, Fadil ;
Barbare, Jean Claude ;
Bedenne, Laurent .
QUALITY OF LIFE RESEARCH, 2008, 17 (06) :831-843
[4]   Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[5]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[6]   Prognostic prediction and treatment strategy in hepatocellular carcinoma [J].
Bruix, J ;
Llovet, JM .
HEPATOLOGY, 2002, 35 (03) :519-524
[7]   Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: A case cohort study [J].
Carr, Brian I. ;
Buch, Shama C. ;
Kondragunta, Venkateswarlu ;
Pancoska, Petr ;
Branch, Robert A. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (08) :1259-1266
[8]   Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: Evaluation of damage to nontumorous liver tissue-long-term prospective study [J].
Caturelli, E ;
Siena, DA ;
Fusilli, S ;
Villani, MR ;
Schiavone, G ;
Nardella, M ;
Balzano, S ;
Florio, F .
RADIOLOGY, 2000, 215 (01) :123-128
[9]   Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization [J].
Cho, Yun Ku ;
Chung, Jin Wook ;
Kim, Jae Kyun ;
Ahn, Yong Sik ;
Kim, Mi Young ;
Park, Yoon Ok ;
Kim, Wan Tae ;
Byun, Jong Hoon .
CANCER, 2008, 112 (02) :352-361
[10]   A simple prognostic scoring system for patients with unresectable hepatocellular carcinoma treated by chemo-embolization [J].
Dvorchik, Igor ;
Carr, Brian I. .
CANCER DETECTION AND PREVENTION, 2007, 31 (02) :154-160